Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 6
Journal homepage
472
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Rheumatoid Arthritis

New adalimumab formulation associated with less injection site pain and improved motivation for treatment

Tomohiko YoshidaSetagaya Rheumatology Clinic, Tokyo, Japan; ;Rheumatology, Toshin Yoshida Internal Medicine, Nagano, Japan; Correspondence[email protected]
,
Yasuhiro OtakiSetagaya Rheumatology Clinic, Tokyo, Japan; ;General Medical Education and Research Center, Teikyo University, Tokyo, Japan
,
Naooki KatsuyamaSetagaya Rheumatology Clinic, Tokyo, Japan; ;Rheumatology, Toshin Yoshida Internal Medicine, Nagano, Japan;
,
Michiko SekiSetagaya Rheumatology Clinic, Tokyo, Japan;
&
Junko KubotaRheumatology, Toshin Yoshida Internal Medicine, Nagano, Japan;
Pages 949-953 | Received 01 Nov 2017, Accepted 03 Sep 2018, Published online: 29 May 2019

References

  • Jaber A, Bozzato GB, Vedrine L, et al. A novel needle for subcutaneous injection of interferon beta-Ia:effect on pain in volunteers and satisfaction in patients with multiple sclerosis. BMC Neurol. 2008;8(38). DOI:10.1186/1471-2377-8-38
  • Frenken LA, van Lier HJ, Jordans JG, Leunissen KM, van Leusen R, Verstappen VM, et al. Identification of the component part in an epoetin alfa preparation that causes pain after subcutaneous injection. Am J Kidney Dis. 1993;22(4):553–6.
  • Frenken LAM, van Lier HJI, Koene RAP. Analysis of the efficacy of measures to reduce pain after subcutaneous administration of epoetin alfa. Nephrol Dial Transplant. 1994;9(9):1295–8.
  • Fransson J, Espander-Jansson A. Local tolerance of subcutaneous injections. J Pharm Pharmacol. 1996;48(10):1012–5.
  • Laursen T, Hansen B, Fisker S. Pain perception after subcutaneous injections of media containing different buffers. Basic Clin Pharmacol Toxicol. 2006;98(2):218–21.
  • Bolge S, Eldridge H, Doshi D, et. al. Patient satisfaction and experience with golimumab, adalimumab, and etanercept for the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Arthritis Rheum. 2012;64:817.
  • Moro T. Comparison of pain levels at subcutaneous injection of biological drugs. Clin Rheumatol. 2014;26:126–9.
  • Nash P, Vanhoof J, Hall S, Arulmani U, Tarzynski-Potempa R, Unnebrink K, et al. Randomized crossover comparison of injection site pain with 40 mg/0.4 or 0.8 ml formulations of adalimumab in patients with rheumatoid arthritis. Rheumatol Ther. 2016;3(2):257–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.